Stevens-Johnson syndrome primary prevention

Stevens-Johnson syndrome Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Stevens-Johnson Syndrome from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
Diagnostic Study of Choice
History and Symptoms
Physical Examination
Laboratory Findings
Electrocardiogram
X Ray
Echocardiography and Ultrasound
CT
MRI
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Stevens-Johnson syndrome primary prevention On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Stevens-Johnson syndrome primary prevention All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Stevens-Johnson syndrome primary prevention
CDC on Stevens-Johnson syndrome primary prevention
Stevens-Johnson syndrome primary prevention in the news
Blogs on Stevens-Johnson syndrome primary prevention
Directions to Hospitals Treating Stevens-Johnson syndrome
Risk calculators and risk factors for Stevens-Johnson syndrome primary prevention

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Anila Hussain, MD [2]

Overview

There are no established measures for the primary prevention of SJS

Primary Prevention

There are no established measures for the primary prevention of SJS. However, for people of Chinese, Indian or Southeast Asian descent, consultation with a physician is recommended before taking carbamazepine. People with a gene called HLA-B*1502 have an increased risk of Stevens-Johnson syndrome if they take this drug.